Skip to Main content Skip to Navigation
Journal articles

DNA methylation changes in cystic fibrosis: Cause or consequence?

Abstract : Twin and sibling studies have shown that lung disease severity is variable among cystic fibrosis (CF) patients and affected to the same extent by genetic and nonheritable factors. Genetic factors have been thoroughly assessed, whereas the molecular mechanisms whereby nonheritable factors contribute to the phenotypic variability of CF patients are still unknown. Epigenetic modifications may represent the missing link between nonheritable factors and phenotypic variation in CF. Herein, we review recent studies showing that DNA methylation is altered in CF and we address three possible factors responsible for these variations: (i) overproduction of reactive oxygen species, (ii) depletion of DNA methylation cofactors and (iii) susceptibility to acute and chronic bacterial infections. Also, we hypothesize that the unique DNA methylation profile of each patient can modulate the phenotype and discuss the interest of implementing integrated genomic, epigenomic and transcriptomic studies to further understand the clinical diversity of CF patients (Graphical Abstract).
Complete list of metadata
Contributor : Albertina DE SARIO Connect in order to contact the contributor
Submitted on : Wednesday, December 15, 2021 - 10:45:24 AM
Last modification on : Tuesday, March 15, 2022 - 9:39:00 AM
Long-term archiving on: : Wednesday, March 16, 2022 - 6:26:04 PM


2020 Scott e De Sario DNA met...
Files produced by the author(s)




Madeleine Scott, Albertina de Sario. DNA methylation changes in cystic fibrosis: Cause or consequence?. Clinical Genetics, Wiley, 2020, 98 (1), pp.3-9. ⟨10.1111/cge.13731⟩. ⟨inserm-03015303⟩



Record views


Files downloads